Medication-Related Osteonecrosis of the Jaws: Considerations on a New Antiresorptive Therapy (Denosumab) and Treatment Outcome after a 13-Year Experience

Table 4

MRONJ staging in osteoporotic patients.

Antiresorptive drug	AAOMS staging system [5]				Dimensional staging system [14]
	Stage 0	Stage I	Stage II	Stage III	Stage 0	Stage I	Stage II	Stage III
Zoledronate		3	2			4	1
Denosumab				2				2
Alendronate		3	31	5		10	15	14
Clodronate			9	2		3	4	4
Risedronate		1	6	4		1	5	5
Ibandronate			7	1			5	3
Off-label			4	3			5	2